メニュー 戻るLS32 Current Status and Prospects for the Future of Decentralized Clinical Trials Utilizing Medical Institution Collaboration

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS32 Current Status and Prospects for the Future of Decentralized Clinical Trials Utilizing Medical Institution Collaboration

Session Chair(s)

Takashi  Sawada

Takashi Sawada

  • Sr. Scientist, Oncology Clinical Developoment
  • MSD K.K., Japan

Speaker(s)

Noboru  Yamamoto, MD, PhD

Noboru Yamamoto, MD, PhD

  • Deputy Director, Department of Experimental Therapeutics
  • National Cancer Center Hospital, Japan
Atsushi  Kitamura, MS

Atsushi Kitamura, MS

  • Director, Clinical Development Quality
  • Pfizer R&D Japan K.K., Japan
Chika  Akiyama

Chika Akiyama

  • GLOBAL MONITORING OPERATIONS
  • PAREXEL INTERNATIONAL INC. JAPAN, Japan